Bellevue Healthcare Trust plc (the "Company")

LEI: 213800HQ3J3H9YF2UI82

Statement re: Target total dividend for the financial year ending 30 November 2024

As stated in the Company's IPO prospectus and in the Company's prospectus dated 5 November 2018, the Company aims to target a dividend each financial year equal to 3.5 per cent of the Net Asset Value as at the last day of the Company's preceding financial year.

The Company intends to pay dividends on a semi-annual basis, by way of two equal dividends, with dividends declared in July and paid in August / September and proposed in February / March and paid in March / April in each year.

For the financial year ended 30 November 2023 the Company paid an interim dividend of 2.995p per ordinary share in August 2023 and in due course the Board is intending to propose a final dividend of 2.995p per ordinary share.

For the financial year ending 30 November 2024, the target total dividend will be 5.04p per ordinary share, this being 3.5 per cent of the unaudited net asset value per ordinary share of 143.87p per ordinary share (including current financial year revenue items) as at 30 November 2023. The Board intends to declare an interim dividend of 2.52p per ordinary share, being half of the target total dividend for the financial year ending 30 November 2024, in July 2024 and intends to pay this dividend in August / September 2024. The Board intends to propose a final dividend of 2.52p per ordinary share for the financial year ending 30 November 2024, in February / March 2025 and intends to pay this dividend in March / April 2025.

The Company pays dividends from distributable reserves. This announcement of a target dividend for the financial year ending 30 November 2024 should not be taken to imply a profit forecast by the Company.

Enquiries:

Mark Ghahramani                                                          

Bellevue Asset Management (UK) Ltd

Tel: +44 (0)20 3871 2862

January 2024